Court Place Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $409K | Sell |
16,058
-1,745
| -10% | -$43.1K | 0.12% | 106 |
|
|
2025
Q2 | $432K | Hold |
17,803
| – | – | 0.14% | 106 |
|
|
2025
Q1 | $451K | Sell |
17,803
-1,569
| -8% | -$41.1K | 0.15% | 99 |
|
|
2024
Q4 | $514K | Sell |
19,372
-12,382
| -39% | -$336K | 0.17% | 94 |
|
|
2024
Q3 | $919K | Buy |
31,754
+2,807
| +10% | +$81.9K | 0.27% | 78 |
|
|
2024
Q2 | $810K | Buy |
28,947
+3,169
| +12% | +$87.2K | 0.25% | 78 |
|
|
2024
Q1 | $715K | Sell |
25,778
-22,479
| -47% | -$624K | 0.23% | 81 |
|
|
2023
Q4 | $1.39M | Sell |
48,257
-12,185
| -20% | -$368K | 0.46% | 55 |
|
|
2023
Q3 | $2M | Sell |
60,442
-5,574
| -8% | -$197K | 0.71% | 38 |
|
|
2023
Q2 | $2.42M | Sell |
66,016
-4,636
| -7% | -$180K | 0.85% | 31 |
|
|
2023
Q1 | $2.88M | Sell |
70,652
-4,033
| -5% | -$174K | 1.04% | 24 |
|
|
2022
Q4 | $3.83M | Sell |
74,685
-1,740
| -2% | -$83.4K | 1.39% | 19 |
|
|
2022
Q3 | $3.34M | Sell |
76,425
-1,146
| -1% | -$55.7K | 1.35% | 20 |
|
|
2022
Q2 | $4.07M | Sell |
77,571
-745
| -1% | -$38K | 1.54% | 17 |
|
|
2022
Q1 | $4.05M | Sell |
78,316
-10,011
| -11% | -$519K | 1.31% | 20 |
|
|
2021
Q4 | $5.22M | Sell |
88,327
-3,932
| -4% | -$195K | 1.44% | 17 |
|
|
2021
Q3 | $3.97M | Sell |
92,259
-1,879
| -2% | -$83.2K | 1.17% | 20 |
|
|
2021
Q2 | $3.69M | Sell |
94,138
-982
| -1% | -$38.2K | 1.07% | 23 |
|
|
2021
Q1 | $3.45M | Sell |
95,120
-187
| -0.2% | -$6.64K | 1.07% | 22 |
|
|
2020
Q4 | $3.51M | Sell |
95,307
-544
| -0.6% | -$20K | 1.17% | 22 |
|
|
2020
Q3 | $3.34M | Buy |
95,851
+7,020
| +8% | +$246K | 1.25% | 19 |
|
|
2020
Q2 | $2.76M | Sell |
88,831
-198
| -0.2% | -$6.73K | 1.07% | 25 |
|
|
2020
Q1 | $2.76M | Sell |
89,029
-831
| -0.9% | -$28.3K | 1.24% | 21 |
|
|
2019
Q4 | $3.34M | Sell |
89,860
-515
| -0.6% | -$18.3K | 1.2% | 20 |
|
|
2019
Q3 | $3.08M | Sell |
90,375
-620
| -0.7% | -$22.5K | 1.19% | 22 |
|
|
2019
Q2 | $3.74M | Buy |
90,995
+4,478
| +5% | +$178K | 1.47% | 17 |
|
|
2019
Q1 | $3.49M | Buy |
86,517
+80
| +0.1% | +$3.2K | 1.41% | 18 |
|
|
2018
Q4 | $3.58M | Sell |
86,437
-95
| -0.1% | -$3.94K | 1.63% | 16 |
|
|
2018
Q3 | $3.62M | Sell |
86,532
-94
| -0.1% | -$3.62K | 1.37% | 19 |
|
|
2018
Q2 | $2.98M | Sell |
86,626
-186
| -0.2% | -$6.36K | 1.24% | 21 |
|
|
2018
Q1 | $2.92M | Buy |
86,812
+4,124
| +5% | +$142K | 1.22% | 24 |
|
|
2017
Q4 | $2.84M | Sell |
82,688
-937
| -1% | -$31.9K | 1.17% | 26 |
|
|
2017
Q3 | $2.83M | Sell |
83,625
-723
| -0.9% | -$23.2K | 1.26% | 23 |
|
|
2017
Q2 | $2.69M | Sell |
84,348
-94
| -0.1% | -$2.96K | 1.28% | 22 |
|
|
2017
Q1 | $2.74M | Buy |
84,442
+6,037
| +8% | +$190K | 1.35% | 21 |
|
|
2016
Q4 | $2.42M | Buy |
78,405
+710
| +0.9% | +$21.7K | 1.26% | 23 |
|
|
2016
Q3 | $2.5M | Buy |
77,695
+1,901
| +3% | +$63.6K | 1.39% | 21 |
|
|
2016
Q2 | $2.53M | Buy |
75,794
+2,780
| +4% | +$88.7K | 1.47% | 20 |
|
|
2016
Q1 | $2.05M | Buy |
73,014
+2,322
| +3% | +$66.3K | 1.27% | 24 |
|
|
2015
Q4 | $2.17M | Buy |
70,692
+543
| +0.8% | +$17.1K | 1.39% | 21 |
|
|
2015
Q3 | $2.09M | Buy |
70,149
+67
| +0.1% | +$2.15K | 1.45% | 20 |
|
|
2015
Q2 | $2.23M | Sell |
70,082
-286
| -0.4% | -$9.32K | 1.42% | 22 |
|
|
2015
Q1 | $2.32M | Sell |
70,368
-840
| -1% | -$26.7K | 1.48% | 22 |
|
|
2014
Q4 | $2.1M | Sell |
71,208
-778
| -1% | -$22.3K | 1.36% | 23 |
|
|
2014
Q3 | $2.02M | Sell |
71,986
-209
| -0.3% | -$5.87K | 1.38% | 24 |
|
|
2014
Q2 | $2.03M | Buy |
72,195
+2,744
| +4% | +$78.2K | 1.41% | 24 |
|
|
2014
Q1 | $2.12M | Sell |
69,451
-261
| -0.4% | -$7.78K | 1.54% | 21 |
|
|
2013
Q4 | $2.03M | Buy |
+69,712
| New | +$2.03M | 1.55% | 21 |
|
Other funds holding PFE
Court Place Advisors's PFE Position: Q3 2025 in Review
Court Place Advisors reduced its Pfizer (PFE) stake by 9.8% in Q3 2025, selling an estimated $43.1K and leaving 16,058 shares worth $409K. The position accounts for 0.12% of the portfolio, ranked #106.
Court Place Advisors first reported a position in PFE in Q4 2013 and has held it in 48 quarters since. The position peaked at $5.22M in Q4 2021. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Court Place Advisors held 16,058 shares of Pfizer worth $409K as of Q3 2025.
- Court Place Advisors sold 1,745 Pfizer shares in Q3 2025, an estimated $43.1K.
- Pfizer made up 0.12% of Court Place Advisors's portfolio in Q3 2025, its #106 holding.
- Court Place Advisors first reported a position in Pfizer in Q4 2013 and has held it in 48 quarters since.
- Court Place Advisors's Pfizer position peaked at $5.22M in Q4 2021.
- 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.